Medical - Pharmaceuticals Stocks
The companies in this industry manufacture and process pharmaceutical products in the treatment of health disorders and illnesses. Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.
Share This Page
B
Industry Rank
This industry ranks #6 out of 123 stock categories.
B
Average POWR Rating
The average market cap-weighted POWR Rating for stocks in this industry is B (Buy).
| Rk | Symbol | Name | Last | Open | High | Low | 52WK Hi | 52WK Lo | Day Chg | YTD Chg | 12M Chg | Mkt Cap | 50D MA | ± 50D | 200D MA | ± 200D | POWR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 169.13 | 166.84 | 169.82 | 166.84 | 169.82 | 101.36 | 2.38 (1.43%) | 29.96% | 51.66% | 161.76B | 155.76 | 8.59% | 134.64 | 25.62% |
A Strong Buy |
| 2 | NVO | Novo Nordisk A/S | 65.88 | 65.53 | 65.89 | 65.31 | 68.71 | 47.24 | 0.82 (1.26%) | 14.96% | 31.21% | 155.13B | 64.83 | 1.62% | 59.13 | 11.41% |
A Strong Buy |
| 3 | ABBV | AbbVie Inc. | 99.28 | 99.75 | 100.57 | 98.55 | 100.69 | 62.55 | -0.07 (-0.07%) | 15.34% | 39.40% | 146.61B | 92.11 | 7.78% | 84.04 | 18.13% |
A Strong Buy |
| 4 | AZN | Astrazeneca PLC | 54.19 | 53.71 | 54.71 | 53.62 | 57.44 | 36.15 | 0.72 (1.35%) | 10.85% | 32.72% | 142.21B | 53.35 | 1.57% | 48.11 | 12.63% |
A Strong Buy |
| 5 | SNY | Sanofi - ADR | 51.52 | 51.41 | 51.61 | 51.15 | 52.94 | 37.62 | 0.09 (0.17%) | 5.15% | 19.84% | 129.01B | 49.63 | 3.81% | 46.96 | 9.72% |
A Strong Buy |
| 6 | ZTS | Zoetis Inc. | 138.81 | 138.72 | 139.69 | 137.43 | 146.26 | 90.14 | 0.37 (0.27%) | 5.20% | 21.66% | 65.93B | 133.54 | 3.95% | 128.67 | 7.88% |
A Strong Buy |
| 7 | BGNE | BeiGene, Ltd. | 204.10 | 199.12 | 204.29 | 195.98 | 210.35 | 114.41 | 7.51 (3.82%) | 23.13% | 59.39% | 15.87B | 170.44 | 19.75% | 161.69 | 26.23% |
A Strong Buy |
| 8 | NBIX | Neurocrine Biosciences, Inc. | 130.11 | 129.45 | 130.76 | 128.24 | 131.00 | 72.14 | 2.15 (1.68%) | 21.04% | 54.45% | 12.08B | 117.89 | 10.37% | 104.65 | 24.33% |
A Strong Buy |
| 9 | HZNP | Horizon Therapeutics Public Limited Company - Ordinary Shares | 58.76 | 57.84 | 58.78 | 57.63 | 59.19 | 22.81 | 1.47 (2.57%) | 62.32% | 155.48% | 11.21B | 47.98 | 22.47% | 36.00 | 63.21% |
A Strong Buy |
| 10 | ACAD | ACADIA Pharmaceuticals Inc. | 56.40 | 57.34 | 58.36 | 56.08 | 58.72 | 21.56 | -0.60 (-1.05%) | 31.84% | 111.00% | 8.79B | 49.45 | 14.05% | 44.31 | 27.29% |
A Strong Buy |
| 11 | RDY | Dr. Reddy's Laboratories Ltd | 52.26 | 51.80 | 52.53 | 51.80 | 55.19 | 33.33 | 0.81 (1.57%) | 28.78% | 39.40% | 8.66B | 52.03 | 0.45% | 44.05 | 18.64% |
A Strong Buy |
| 12 | PCRX | Pacira BioSciences, Inc. | 56.54 | 54.64 | 56.69 | 53.85 | 56.69 | 27.46 | 2.37 (4.38%) | 24.81% | 30.67% | 2.38B | 45.23 | 25.01% | 42.15 | 34.13% |
A Strong Buy |
| 13 | AMPH | Amphastar Pharmaceuticals, Inc. | 21.50 | 21.60 | 21.72 | 21.35 | 22.85 | 12.32 | -0.06 (-0.28%) | 11.46% | 5.76% | 993.26M | 19.49 | 10.29% | 18.45 | 16.51% |
A Strong Buy |
| 14 | RTRX | Retrophin, Inc. | 20.82 | 20.85 | 21.28 | 20.49 | 21.91 | 8.98 | -0.07 (-0.34%) | 46.62% | 3.53% | 898.51M | 16.66 | 24.94% | 14.64 | 42.17% |
A Strong Buy |
| 15 | ASMB | Assembly Biosciences, Inc. | 24.21 | 24.47 | 25.45 | 23.68 | 25.45 | 8.13 | 0.30 (1.25%) | 18.33% | 76.97% | 792.20M | 20.83 | 16.23% | 17.52 | 38.20% |
A Strong Buy |
| 16 | SYRS | Syros Pharmaceuticals, Inc. - common stock | 12.00 | 11.64 | 12.57 | 11.55 | 12.57 | 4.26 | 0.43 (3.72%) | 73.66% | 42.69% | 548.32M | 9.71 | 23.62% | 7.49 | 60.32% |
A Strong Buy |
| 17 | PTGX | Protagonist Therapeutics, Inc. | 18.64 | 18.48 | 18.97 | 18.35 | 19.67 | 4.47 | 0.29 (1.58%) | 164.40% | 39.31% | 511.39M | 15.19 | 22.68% | 10.32 | 80.67% |
A Strong Buy |
| 18 | SPRO | Spero Therapeutics, Inc. | 14.12 | 13.75 | 14.14 | 13.55 | 14.48 | 5.25 | 0.41 (2.99%) | 46.85% | 27.21% | 290.80M | 12.61 | 11.97% | 10.39 | 35.89% |
A Strong Buy |
| 19 | EPIX | ESSA Pharma Inc. | 6.20 | 6.05 | 6.21 | 6.00 | 6.29 | 1.41 | 0.10 (1.64%) | 12.73% | 170.79% | 129.12M | 5.16 | 20.26% | 4.79 | 29.45% |
A Strong Buy |
| 20 | NVS | Novartis AG | 88.12 | 87.70 | 88.12 | 87.48 | 99.84 | 69.18 | 0.32 (0.36%) | -4.74% | -2.89% | 201.68B | 86.47 | 1.90% | 87.19 | 1.07% |
B Buy |
| 21 | ABT | Abbott Laboratories | 92.58 | 92.84 | 93.67 | 91.50 | 100.00 | 61.61 | 0.12 (0.13%) | 7.49% | 8.80% | 163.76B | 91.13 | 1.59% | 85.52 | 8.25% |
B Buy |
| 22 | BMY | Bristol-Myers Squibb Company | 59.56 | 60.32 | 60.68 | 59.28 | 68.34 | 42.48 | -0.73 (-1.21%) | -5.07% | 30.13% | 134.77B | 59.62 | -0.10% | 58.20 | 2.33% |
B Buy |
| 23 | CTLT | Catalent, Inc. | 76.22 | 74.00 | 76.28 | 73.91 | 80.52 | 31.04 | 2.49 (3.38%) | 35.38% | 39.73% | 11.81B | 72.93 | 4.52% | 57.95 | 31.52% |
B Buy |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 60.91 | 61.00 | 61.61 | 60.01 | 73.09 | 39.32 | -0.48 (-0.78%) | 0.83% | -4.86% | 8.49B | 57.14 | 6.60% | 57.20 | 6.49% |
B Buy |
| 25 | PRGO | Perrigo Company plc Ordinary Shares | 54.93 | 55.36 | 55.36 | 54.26 | 63.86 | 40.01 | -0.27 (-0.49%) | 7.16% | 8.56% | 7.49B | 54.03 | 1.66% | 52.64 | 4.36% |
B Buy |
| 26 | UTHR | United Therapeutics Corporation | 117.78 | 118.58 | 119.70 | 116.94 | 127.79 | 74.31 | -0.82 (-0.69%) | 33.72% | 50.79% | 5.18B | 117.48 | 0.25% | 98.54 | 19.52% |
B Buy |
| 27 | MOR | MorphoSys AG | 33.39 | 33.50 | 33.57 | 33.24 | 37.96 | 18.21 | 0.39 (1.18%) | -6.39% | 37.41% | 4.39B | 30.94 | 7.91% | 29.53 | 13.05% |
B Buy |
| 28 | DNLI | Denali Therapeutics Inc. | 27.10 | 26.77 | 27.24 | 26.26 | 30.41 | 12.39 | 0.47 (1.76%) | 55.57% | 35.98% | 2.86B | 25.11 | 7.92% | 20.35 | 33.19% |
B Buy |
| 29 | MYOV | Myovant Sciences Ltd. Common Shares | 19.34 | 19.50 | 19.53 | 18.70 | 22.07 | 4.14 | 0.17 (0.89%) | 24.61% | 131.62% | 1.74B | 15.45 | 25.19% | 11.64 | 66.14% |
B Buy |
| 30 | MDGL | Madrigal Pharmaceuticals, Inc. | 110.00 | 109.06 | 110.00 | 106.68 | 127.25 | 56.82 | 1.53 (1.41%) | 20.73% | 9.69% | 1.70B | 108.14 | 1.72% | 93.27 | 17.93% |
B Buy |
| 31 | KNSA | Kiniksa Pharmaceuticals, Ltd. - | 23.27 | 22.89 | 24.05 | 22.89 | 28.67 | 5.01 | 0.42 (1.84%) | 110.40% | 66.45% | 1.39B | 22.18 | 4.92% | 15.06 | 54.55% |
B Buy |
| 32 | ODT | Odonate Therapeutics, Inc. | 38.88 | 38.61 | 39.69 | 38.33 | 46.50 | 18.07 | 0.22 (0.57%) | 19.82% | 4.77% | 1.25B | 34.98 | 11.14% | 30.96 | 25.58% |
B Buy |
| 33 | ARCT | Arcturus Therapeutics Holdings Inc. | 51.16 | 50.00 | 51.44 | 48.43 | 62.97 | 8.49 | 1.50 (3.02%) | 370.65% | 451.89% | 1.02B | 42.07 | 21.60% | 19.76 | 158.96% |
B Buy |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 22.00 | 21.70 | 22.16 | 21.26 | 25.86 | 12.99 | 0.30 (1.38%) | -4.18% | 0.59% | 970.02M | 20.60 | 6.79% | 20.03 | 9.84% |
B Buy |
| 35 | REPL | Replimune Group, Inc. | 23.01 | 22.67 | 23.34 | 22.39 | 26.22 | 8.58 | 0.49 (2.18%) | 60.35% | 67.96% | 846.40M | 20.50 | 12.25% | 15.81 | 45.57% |
B Buy |
| 36 | CLLS | Cellectis S.A. | 17.65 | 17.25 | 17.93 | 16.91 | 21.97 | 7.32 | 1.33 (8.15%) | 3.10% | 10.80% | 749.52M | 17.03 | 3.63% | 14.46 | 22.08% |
B Buy |
| 37 | KMDA | Kamada Ltd. - Ordinary Shares | 8.34 | 8.40 | 8.46 | 8.12 | 9.91 | 4.40 | 0.06 (0.72%) | 22.11% | 43.79% | 371.30M | 7.90 | 5.53% | 6.56 | 27.11% |
B Buy |
| 38 | CDMO | Avid Bioservices, Inc. | 6.53 | 6.90 | 6.90 | 6.47 | 8.38 | 3.02 | -0.37 (-5.36%) | -14.86% | 4.31% | 369.02M | 6.03 | 8.23% | 5.84 | 11.84% |
B Buy |
| 39 | MEIP | MEI Pharma, Inc. | 3.41 | 3.48 | 3.48 | 3.35 | 4.46 | 0.72 | -0.02 (-0.58%) | 37.50% | 48.91% | 361.46M | 3.46 | -1.36% | 2.31 | 47.43% |
B Buy |
| 40 | OSMT | Osmotica Pharmaceuticals plc - Ordinary Shares | 6.36 | 6.41 | 6.69 | 6.28 | 7.97 | 2.70 | -0.04 (-0.62%) | -9.01% | 66.93% | 327.67M | 5.49 | 15.82% | 5.18 | 22.79% |
B Buy |
| 41 | APTX | Aptinyx Inc. | 4.77 | 4.75 | 4.89 | 4.60 | 5.28 | 1.60 | 0.04 (0.85%) | 39.47% | 32.50% | 217.78M | 3.88 | 22.94% | 3.41 | 39.73% |
B Buy |
| 42 | SURF | Surface Oncology, Inc. | 6.21 | 6.72 | 6.73 | 6.14 | 7.66 | 1.15 | -0.29 (-4.46%) | 230.32% | 136.12% | 175.88M | 4.33 | 43.25% | 2.69 | 130.46% |
B Buy |
| 43 | JNJ | Johnson & Johnson | 143.27 | 142.87 | 143.39 | 141.70 | 157.00 | 109.16 | 0.42 (0.29%) | -0.47% | 1.63% | 377.46B | 145.22 | -1.34% | 139.27 | 2.87% |
C Neutral |
| 44 | MRK | Merck & Company, Inc. (new) | 77.92 | 78.63 | 78.96 | 77.48 | 92.64 | 65.25 | -0.80 (-1.02%) | -12.93% | -7.28% | 196.68B | 77.88 | 0.06% | 81.23 | -4.08% |
C Neutral |
| 45 | PFE | Pfizer, Inc. | 33.75 | 34.01 | 34.37 | 33.57 | 44.10 | 27.88 | -0.28 (-0.82%) | -12.11% | -22.06% | 187.48B | 35.73 | -5.55% | 35.85 | -5.86% |
C Neutral |
| 46 | GSK | GlaxoSmithKline PLC | 40.73 | 40.57 | 40.79 | 40.38 | 48.25 | 31.43 | 0.35 (0.87%) | -11.23% | 0.52% | 102.17B | 41.29 | -1.37% | 41.92 | -2.84% |
C Neutral |
| 47 | TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | 11.40 | 11.23 | 11.40 | 11.11 | 13.76 | 6.07 | 0.19 (1.69%) | 16.33% | 24.32% | 12.45B | 11.86 | -3.86% | 10.09 | 13.01% |
C Neutral |
| 48 | ALLO | Allogene Therapeutics, Inc. | 44.22 | 44.33 | 44.82 | 43.72 | 55.00 | 17.43 | 0.14 (0.32%) | 70.21% | 65.93% | 5.54B | 41.24 | 7.23% | 29.54 | 49.69% |
C Neutral |
| 49 | MYOK | MyoKardia, Inc. | 95.29 | 94.06 | 95.57 | 93.50 | 126.30 | 42.65 | 1.25 (1.33%) | 30.74% | 97.41% | 4.45B | 94.63 | 0.70% | 69.52 | 37.07% |
C Neutral |
| 50 | MNTA | Momenta Pharmaceuticals, Inc. | 34.50 | 33.89 | 34.55 | 33.28 | 39.88 | 9.51 | 0.74 (2.19%) | 74.86% | 193.12% | 4.06B | 33.09 | 4.28% | 25.01 | 37.96% |
C Neutral |
| 51 | GWPH | GW Pharmaceuticals Plc | 129.00 | 129.36 | 129.59 | 127.71 | 180.75 | 67.98 | -0.62 (-0.48%) | 23.37% | -25.50% | 4.01B | 120.64 | 6.93% | 111.25 | 15.95% |
C Neutral |
| 52 | ALKS | Alkermes plc - Ordinary Shares | 20.41 | 20.11 | 20.64 | 19.76 | 25.35 | 11.98 | 0.32 (1.57%) | 0.05% | -8.82% | 3.24B | 16.87 | 20.98% | 18.11 | 12.71% |
C Neutral |
| 53 | AXSM | Axsome Therapeutics, Inc. | 85.84 | 83.96 | 85.87 | 82.16 | 109.94 | 13.64 | 1.96 (2.34%) | -16.95% | 213.28% | 3.18B | 82.18 | 4.45% | 65.24 | 31.57% |
C Neutral |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 31.74 | 31.01 | 31.76 | 30.91 | 45.04 | 16.85 | 0.77 (2.49%) | 3.66% | 22.45% | 2.40B | 32.45 | -2.17% | 31.51 | 0.73% |
C Neutral |
| 55 | EIDX | Eidos Therapeutics, Inc. | 49.24 | 49.74 | 50.50 | 48.88 | 66.56 | 28.00 | -0.50 (-1.01%) | -14.20% | 34.87% | 1.90B | 46.67 | 5.50% | 48.65 | 1.22% |
C Neutral |
| 56 | PRNB | Principia Biopharma Inc. | 56.38 | 56.89 | 57.84 | 55.69 | 75.65 | 25.35 | -0.44 (-0.77%) | 2.92% | 47.55% | 1.86B | 61.52 | -8.36% | 51.81 | 8.82% |
C Neutral |
| 57 | AUPH | Aurinia Pharmaceuticals Inc | 15.61 | 15.27 | 15.87 | 15.21 | 21.93 | 3.52 | 0.33 (2.16%) | -22.95% | 145.83% | 1.76B | 16.17 | -3.46% | 14.02 | 11.37% |
C Neutral |
| 58 | YMAB | Y-mAbs Therapeutics, Inc. | 41.74 | 41.63 | 42.05 | 40.83 | 50.49 | 14.16 | 0.14 (0.34%) | 33.57% | 85.02% | 1.66B | 40.98 | 1.85% | 32.27 | 29.34% |
C Neutral |
| 59 | IRWD | Ironwood Pharmaceuticals, Inc. - | 9.99 | 10.14 | 10.23 | 9.91 | 14.10 | 7.91 | -0.18 (-1.72%) | -24.94% | -1.87% | 1.59B | 10.30 | -2.97% | 10.92 | -8.48% |
C Neutral |
| 60 | ZEAL | Zealand Pharma A/S | 36.96 | 36.66 | 36.96 | 36.36 | 44.60 | 18.75 | 0.12 (0.33%) | 11.33% | 67.39% | 1.47B | 36.51 | 1.23% | 33.19 | 11.36% |
C Neutral |
| 61 | SUPN | Supernus Pharmaceuticals, Inc. | 23.38 | 23.05 | 23.44 | 22.59 | 34.11 | 13.12 | 0.32 (1.39%) | -1.43% | -26.41% | 1.23B | 23.54 | -0.70% | 22.67 | 3.14% |
C Neutral |
| 62 | ATNX | Athenex, Inc. | 13.37 | 13.36 | 13.59 | 12.96 | 21.11 | 5.63 | 0.06 (0.45%) | -12.44% | -35.97% | 1.09B | 11.67 | 14.61% | 12.19 | 9.65% |
C Neutral |
| 63 | BTAI | BioXcel Therapeutics, Inc. | 53.42 | 51.27 | 53.49 | 49.11 | 61.50 | 3.76 | 3.44 (6.88%) | 265.64% | 403.49% | 1.08B | 47.52 | 12.42% | 23.36 | 128.71% |
C Neutral |
| 64 | FIXX | Homology Medicines, Inc. | 15.58 | 16.60 | 16.88 | 15.33 | 24.00 | 11.05 | -1.01 (-6.09%) | -24.73% | -15.74% | 704.42M | 14.71 | 5.88% | 15.98 | -2.51% |
C Neutral |
| 65 | CUE | Cue Biopharma, Inc. | 23.54 | 22.82 | 23.60 | 22.30 | 31.69 | 6.54 | 0.84 (3.70%) | 48.28% | 201.02% | 669.71M | 25.97 | -9.35% | 16.80 | 40.09% |
C Neutral |
| 66 | EGRX | Eagle Pharmaceuticals, Inc. | 46.35 | 46.84 | 47.40 | 45.63 | 64.94 | 33.80 | -0.51 (-1.09%) | -22.85% | -16.50% | 634.30M | 50.16 | -7.60% | 53.22 | -12.91% |
C Neutral |
| 67 | MTEM | Molecular Templates, Inc. | 13.85 | 14.46 | 14.46 | 13.76 | 19.12 | 4.51 | -0.56 (-3.89%) | -0.97% | 85.91% | 633.36M | 15.39 | -10.00% | 13.02 | 6.38% |
C Neutral |
| 68 | TRIL | Trillium Therapeutics Inc. | 7.46 | 7.28 | 7.74 | 7.12 | 9.66 | 0.24 | 0.17 (2.33%) | 624.27% | 2,021.73% | 622.43M | 7.00 | 6.52% | 3.44 | 116.56% |
C Neutral |
| 69 | KALA | Kala Pharmaceuticals, Inc. | 10.64 | 10.70 | 10.96 | 10.50 | 14.68 | 3.24 | -0.05 (-0.47%) | 188.35% | 72.73% | 580.66M | 11.99 | -11.25% | 7.18 | 48.11% |
C Neutral |
| 70 | SNDX | Syndax Pharmaceuticals, Inc. | 15.68 | 15.52 | 15.71 | 14.86 | 21.97 | 5.35 | 0.24 (1.55%) | 78.59% | 72.12% | 565.97M | 16.93 | -7.40% | 10.68 | 46.82% |
C Neutral |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 5.08 | 5.02 | 5.15 | 5.00 | 7.67 | 2.55 | 0.06 (1.20%) | 35.47% | 28.93% | 525.35M | 4.59 | 10.62% | 4.47 | 13.69% |
C Neutral |
| 72 | VKTX | Viking Therapeutics, Inc. | 6.94 | 6.92 | 7.00 | 6.83 | 8.87 | 3.26 | 0.06 (0.87%) | -13.47% | -16.08% | 503.82M | 7.14 | -2.86% | 6.71 | 3.49% |
C Neutral |
| 73 | MIRM | Mirum Pharmaceuticals, Inc. - common stock | 19.62 | 19.31 | 20.07 | 19.07 | 28.31 | 6.51 | 0.16 (0.82%) | -19.98% | 48.52% | 498.15M | 17.93 | 9.43% | 14.55 | 34.81% |
C Neutral |
| 74 | ACIU | AC Immune SA | 7.27 | 7.38 | 7.48 | 7.23 | 10.14 | 4.07 | -0.01 (-0.14%) | -14.67% | 36.40% | 491.18M | 7.19 | 1.12% | 7.17 | 1.36% |
C Neutral |
| 75 | BYSI | BeyondSpring, Inc. - Ordinary Shares | 15.84 | 16.12 | 16.48 | 15.58 | 23.00 | 9.38 | -0.29 (-1.80%) | 2.19% | -21.62% | 476.91M | 16.24 | -2.48% | 15.22 | 4.08% |
C Neutral |
| 76 | ALBO | Albireo Pharma, Inc. | 25.50 | 26.20 | 26.43 | 25.00 | 32.38 | 11.26 | -0.07 (-0.27%) | 0.31% | -19.30% | 381.99M | 26.02 | -2.00% | 21.96 | 16.10% |
C Neutral |
| 77 | ABEO | Abeona Therapeutics Inc. | 3.42 | 3.52 | 3.78 | 3.31 | 5.19 | 1.35 | 0.02 (0.59%) | 4.59% | -22.27% | 286.25M | 2.95 | 15.97% | 2.76 | 24.06% |
C Neutral |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 13.79 | 13.52 | 14.19 | 13.33 | 19.97 | 2.95 | 0.27 (2.00%) | 83.87% | 69.20% | 281.30M | 9.72 | 41.93% | 7.58 | 81.96% |
C Neutral |
| 79 | NYMX | Nymox Pharmaceutical Corporation | 3.46 | 3.51 | 3.51 | 3.41 | 4.79 | 1.49 | -0.02 (-0.57%) | 57.27% | 135.71% | 246.42M | 3.49 | -0.73% | 2.64 | 30.84% |
C Neutral |
| 80 | RDHL | Redhill Biopharma Ltd. | 6.97 | 7.06 | 7.18 | 6.81 | 9.12 | 3.26 | -0.05 (-0.71%) | 14.83% | 5.29% | 245.83M | 7.00 | -0.40% | 6.16 | 13.20% |
C Neutral |
| 81 | TLC | Taiwan Liposome Company, Ltd. - ADRs | 6.31 | 6.43 | 6.43 | 6.23 | 8.54 | 2.48 | 0.39 (6.58%) | 17.29% | 24.46% | 234.08M | 5.25 | 20.19% | 4.98 | 26.79% |
C Neutral |
| 82 | VERU | Veru Inc. | 3.19 | 3.19 | 3.21 | 3.07 | 4.74 | 1.67 | 0.00 (0.00%) | -4.78% | 39.91% | 216.94M | 3.51 | -9.19% | 3.11 | 2.66% |
C Neutral |
| 83 | FENC | Fennec Pharmaceuticals Inc. | 8.50 | 8.09 | 8.53 | 7.95 | 9.75 | 3.75 | 0.44 (5.46%) | 30.97% | 112.50% | 215.53M | 7.79 | 9.12% | 6.43 | 32.09% |
C Neutral |
| 84 | LQDA | Liquidia Technologies, Inc. | 7.55 | 8.02 | 8.02 | 7.13 | 12.10 | 2.65 | -0.32 (-4.07%) | 76.61% | -8.26% | 214.21M | 8.23 | -8.22% | 5.52 | 36.68% |
C Neutral |
| 85 | KALV | KalVista Pharmaceuticals, Inc. | 11.76 | 11.86 | 12.08 | 11.43 | 19.16 | 5.61 | -0.10 (-0.84%) | -33.97% | -35.31% | 209.87M | 11.19 | 5.08% | 12.39 | -5.07% |
C Neutral |
| 86 | SBBP | Strongbridge Biopharma plc - Ordinary Shares | 3.84 | 3.80 | 3.88 | 3.73 | 4.63 | 1.43 | 0.02 (0.52%) | 83.73% | 25.08% | 208.31M | 3.43 | 12.00% | 2.53 | 51.64% |
C Neutral |
| 87 | ATXI | Avenue Therapeutics, Inc. | 9.90 | 9.72 | 9.96 | 9.70 | 11.83 | 4.96 | 0.20 (2.06%) | 3.13% | 61.24% | 165.16M | 10.45 | -5.23% | 8.34 | 18.71% |
C Neutral |
| 88 | ORGS | Orgenesis Inc. | 5.97 | 5.95 | 6.04 | 5.74 | 8.20 | 2.35 | 0.02 (0.34%) | 28.11% | 36.30% | 131.32M | 6.56 | -8.97% | 4.60 | 29.70% |
C Neutral |
| 89 | TRVI | Trevi Therapeutics, Inc. | 5.49 | 5.99 | 6.00 | 5.18 | 8.49 | 1.33 | 0.00 (0.00%) | 46.40% | -26.80% | 97.96M | 4.09 | 34.18% | 4.01 | 36.86% |
C Neutral |
| 90 | ACRS | Aclaris Therapeutics, Inc. | 1.74 | 1.82 | 1.85 | 1.71 | 2.45 | 0.70 | -0.03 (-1.69%) | -7.94% | -19.07% | 72.85M | 1.44 | 20.81% | 1.45 | 19.79% |
C Neutral |
| 91 | VBLT | Vascular Biogenics Ltd. - Ordinary Shares | 1.25 | 1.25 | 1.30 | 1.23 | 1.64 | 0.90 | -0.01 (-0.79%) | 4.17% | -3.10% | 52.41M | 1.27 | -1.83% | 1.29 | -2.91% |
C Neutral |
| 92 | GRFS | Grifols, S.A. | 18.59 | 18.75 | 19.00 | 18.49 | 25.73 | 13.40 | -0.11 (-0.59%) | -20.18% | -14.53% | 12.78B | 19.56 | -4.95% | 21.20 | -12.32% |
D Sell |
| 93 | ELAN | Elanco Animal Health Incorporated | 21.65 | 21.52 | 21.85 | 21.33 | 35.23 | 15.17 | 0.10 (0.46%) | -26.49% | -35.10% | 8.64B | 21.68 | -0.12% | 25.49 | -15.07% |
D Sell |
| 94 | MYL | Mylan N.V. | 16.19 | 16.07 | 16.26 | 15.88 | 23.11 | 12.75 | 0.08 (0.50%) | -19.45% | -15.98% | 8.37B | 16.55 | -2.18% | 18.00 | -10.06% |
D Sell |
| 95 | BHC | Bausch Health Companies Inc. | 17.55 | 18.45 | 18.45 | 17.22 | 31.97 | 11.15 | -0.88 (-4.77%) | -41.34% | -29.49% | 6.23B | 18.18 | -3.44% | 22.46 | -21.87% |
D Sell |
| 96 | NVCR | NovoCure Limited - Ordinary Shares | 60.97 | 59.37 | 61.10 | 59.37 | 98.84 | 53.40 | 1.39 (2.33%) | -27.65% | -5.09% | 6.12B | 63.87 | -4.54% | 74.86 | -18.55% |
D Sell |
| 97 | RETA | Reata Pharmaceuticals, Inc. - | 158.00 | 156.38 | 159.13 | 154.68 | 257.96 | 70.00 | 2.36 (1.52%) | -22.71% | 79.20% | 5.25B | 155.18 | 1.82% | 172.71 | -8.52% |
D Sell |
| 98 | BBIO | BridgeBio Pharma, Inc. | 31.47 | 30.19 | 31.48 | 30.00 | 48.36 | 14.23 | 1.05 (3.45%) | -10.21% | 11.60% | 3.82B | 31.63 | -0.50% | 29.53 | 6.56% |
D Sell |
| 99 | TARO | Taro Pharmaceutical Industries Ltd. Ordinary Shares | 65.81 | 66.75 | 67.83 | 65.64 | 99.69 | 56.07 | -1.14 (-1.70%) | -25.16% | -21.79% | 2.52B | 67.47 | -2.46% | 75.07 | -12.34% |
D Sell |
| 100 | MESO | Mesoblast Limited | 12.95 | 13.17 | 13.19 | 12.76 | 20.57 | 3.12 | 0.21 (1.65%) | 75.71% | 135.03% | 1.51B | 12.32 | 5.09% | 8.27 | 56.56% |
D Sell |
| 101 | KPTI | Karyopharm Therapeutics Inc. | 19.48 | 19.20 | 19.50 | 18.88 | 29.61 | 7.31 | 0.39 (2.04%) | 1.62% | 133.57% | 1.42B | 19.02 | 2.42% | 17.32 | 12.45% |
D Sell |
| 102 | AMRX | Amneal Pharmaceuticals, Inc. | 4.51 | 4.53 | 4.54 | 4.34 | 6.89 | 2.27 | -0.03 (-0.66%) | -6.43% | -33.09% | 1.35B | 4.49 | 0.46% | 3.93 | 14.66% |
D Sell |
| 103 | TCDA | Tricida, Inc. | 26.93 | 26.77 | 26.96 | 26.26 | 44.30 | 18.02 | 0.19 (0.71%) | -28.64% | -21.10% | 1.35B | 27.67 | -2.66% | 32.08 | -16.06% |
D Sell |
| 104 | APHA | Aphria Inc. Common Shares | 4.31 | 4.36 | 4.37 | 4.25 | 7.60 | 1.95 | -0.02 (-0.46%) | -17.43% | -36.15% | 1.23B | 4.07 | 5.94% | 4.29 | 0.40% |
D Sell |
| 105 | APLT | Applied Therapeutics, Inc. | 32.35 | 32.39 | 33.49 | 31.51 | 57.39 | 8.09 | -0.04 (-0.12%) | 18.59% | 300.37% | 715.81M | 42.37 | -23.64% | 32.33 | 0.05% |
D Sell |
| 106 | RDUS | Radius Health, Inc. | 12.99 | 13.60 | 13.76 | 12.67 | 29.97 | 10.32 | -1.07 (-7.61%) | -35.57% | -45.00% | 602.59M | 13.66 | -4.94% | 18.78 | -30.83% |
D Sell |
| 107 | COLL | Collegium Pharmaceutical, Inc. | 17.09 | 17.09 | 17.23 | 16.43 | 25.59 | 10.01 | 0.03 (0.18%) | -16.96% | 37.93% | 586.80M | 19.68 | -13.15% | 18.67 | -8.46% |
D Sell |
| 108 | CRNX | Crinetics Pharmaceuticals, Inc. | 16.40 | 17.37 | 17.43 | 16.24 | 26.67 | 10.63 | -0.82 (-4.76%) | -34.64% | -32.48% | 538.67M | 17.69 | -7.30% | 18.70 | -12.31% |
D Sell |
| 109 | VYGR | Voyager Therapeutics, Inc. | 13.66 | 13.15 | 13.83 | 13.12 | 27.50 | 6.26 | 0.58 (4.43%) | -2.08% | -48.72% | 508.03M | 12.43 | 9.90% | 12.71 | 7.47% |
D Sell |
| 110 | FLXN | Flexion Therapeutics, Inc. | 12.50 | 12.37 | 12.59 | 12.02 | 22.98 | 5.01 | 0.19 (1.54%) | -39.61% | 15.42% | 482.04M | 11.30 | 10.63% | 14.09 | -11.28% |
D Sell |
| 111 | DRRX | DURECT Corporation | 2.21 | 2.17 | 2.23 | 2.14 | 3.95 | 0.64 | 0.04 (1.84%) | -41.84% | 227.31% | 433.22M | 2.35 | -5.83% | 2.06 | 7.03% |
D Sell |
| 112 | TXMD | TherapeuticsMD, Inc. | 1.58 | 1.55 | 1.67 | 1.53 | 4.32 | 0.85 | 0.05 (3.27%) | -34.71% | -38.28% | 429.26M | 1.27 | 24.05% | 2.05 | -23.07% |
D Sell |
| 113 | CTMX | CytomX Therapeutics, Inc. | 8.38 | 8.28 | 8.50 | 8.14 | 15.44 | 3.60 | 0.15 (1.82%) | 0.84% | -24.16% | 384.83M | 9.39 | -10.78% | 7.69 | 8.93% |
D Sell |
| 114 | WVE | Wave Life Sciences Ltd. - Ordinary Shares | 10.00 | 9.98 | 10.35 | 9.65 | 39.98 | 6.61 | 0.36 (3.73%) | 24.77% | -62.12% | 357.32M | 9.96 | 0.42% | 14.36 | -30.36% |
D Sell |
| 115 | RIGL | Rigel Pharmaceuticals, Inc. | 1.96 | 1.88 | 1.96 | 1.85 | 3.10 | 1.23 | 0.06 (3.16%) | -8.41% | -23.44% | 330.40M | 1.88 | 4.37% | 1.99 | -1.29% |
D Sell |
| 116 | UROV | Urovant Sciences Ltd. | 9.86 | 10.07 | 10.13 | 9.75 | 15.98 | 6.55 | -0.21 (-2.09%) | -36.43% | 26.41% | 303.68M | 9.86 | -0.03% | 10.77 | -8.41% |
D Sell |
| 117 | AVDL | Avadel Pharmaceuticals plc each representing one Ordinary Share | 7.61 | 7.72 | 7.78 | 7.50 | 13.49 | 1.82 | -0.12 (-1.55%) | 0.79% | 238.22% | 284.99M | 8.57 | -11.24% | 7.17 | 6.10% |
D Sell |
| 118 | AMAG | AMAG Pharmaceuticals, Inc. | 7.61 | 7.89 | 7.96 | 7.46 | 13.53 | 4.41 | -0.28 (-3.55%) | -37.47% | -21.95% | 260.82M | 7.84 | -2.95% | 9.22 | -17.44% |
D Sell |
| 119 | AGRX | Agile Therapeutics, Inc. | 2.74 | 2.67 | 2.75 | 2.65 | 4.77 | 0.35 | 0.08 (3.01%) | 9.60% | 75.64% | 238.96M | 2.79 | -1.70% | 2.37 | 15.81% |
D Sell |
| 120 | VRCA | Verrica Pharmaceuticals Inc. | 8.80 | 9.62 | 9.92 | 8.76 | 18.67 | 6.79 | -0.86 (-8.90%) | -44.62% | -20.65% | 227.16M | 11.69 | -24.72% | 13.08 | -32.74% |
D Sell |
| 121 | STRO | Sutro Biopharma, Inc. | 8.47 | 8.35 | 8.65 | 8.04 | 12.75 | 6.00 | 0.07 (0.83%) | -23.00% | -25.83% | 196.74M | 9.27 | -8.63% | 10.08 | -15.93% |
D Sell |
| 122 | OPTN | OptiNose, Inc. | 4.25 | 4.65 | 4.92 | 4.21 | 11.66 | 3.28 | -0.29 (-6.39%) | -53.90% | -37.04% | 195.10M | 5.11 | -16.90% | 6.71 | -36.66% |
D Sell |
| 123 | SCPH | scPharmaceuticals Inc. | 8.23 | 7.32 | 8.27 | 7.21 | 11.99 | 3.40 | 0.95 (13.05%) | 45.41% | 135.14% | 172.91M | 8.66 | -5.00% | 7.03 | 17.15% |
D Sell |
| 124 | SLGL | Sol-Gel Technologies Ltd. | 8.37 | 8.56 | 8.56 | 8.25 | 21.00 | 5.00 | -0.20 (-2.33%) | -51.20% | -18.74% | 170.66M | 8.34 | 0.39% | 9.24 | -9.41% |
D Sell |
| 125 | TYME | Tyme Technologies, Inc. | 1.27 | 1.27 | 1.31 | 1.25 | 2.04 | 0.86 | 0.01 (0.79%) | -9.29% | -15.89% | 156.01M | 1.43 | -11.41% | 1.31 | -3.17% |
D Sell |
| 126 | PHAS | PhaseBio Pharmaceuticals, Inc. | 4.65 | 4.82 | 4.89 | 4.49 | 12.34 | 2.60 | -0.08 (-1.69%) | -23.90% | -61.67% | 133.83M | 4.74 | -1.86% | 4.38 | 6.22% |
D Sell |
| 127 | ETON | Eton Pharmaceuticals, Inc. | 5.21 | 5.35 | 5.74 | 5.16 | 9.07 | 2.50 | -0.13 (-2.43%) | -27.64% | -35.28% | 108.98M | 5.30 | -1.68% | 5.68 | -8.27% |
D Sell |
| 128 | SMMT | Summit Therapeutics plc | 3.31 | 3.33 | 3.35 | 3.25 | 5.49 | 1.18 | -0.02 (-0.60%) | 106.88% | 154.62% | 106.25M | 3.49 | -5.04% | 2.26 | 46.44% |
D Sell |
| 129 | UMRX | Unum Therapeutics Inc. | 2.96 | 2.30 | 2.97 | 2.11 | 3.40 | 0.29 | 0.57 (23.85%) | 311.00% | 19.35% | 92.24M | 0.62 | 377.42% | 0.78 | 279.93% |
D Sell |
| 130 | LPCN | Lipocine Inc. | 1.35 | 1.38 | 1.39 | 1.28 | 3.45 | 0.30 | 0.00 (0.00%) | 250.74% | -30.77% | 64.64M | 0.92 | 46.90% | 0.99 | 37.00% |
D Sell |
| 131 | EYEN | Eyenovia, Inc. | 2.81 | 2.75 | 2.82 | 2.73 | 5.06 | 1.11 | 0.00 (0.00%) | -37.28% | -24.05% | 55.57M | 3.14 | -10.44% | 3.42 | -17.82% |
D Sell |
| 132 | NOVN | Novan, Inc. | 0.49 | 0.52 | 0.52 | 0.48 | 3.72 | 0.22 | -0.01 (-2.80%) | -84.49% | -82.73% | 39.18M | 0.44 | 10.71% | 1.15 | -57.53% |
D Sell |
| 133 | ACER | Acer Therapeutics Inc. | 3.22 | 3.13 | 3.22 | 3.03 | 7.25 | 1.08 | 0.09 (2.88%) | -19.70% | -8.52% | 33.00M | 3.19 | 0.98% | 3.29 | -2.12% |
D Sell |
| 134 | IMRN | Immuron Limited | 7.22 | 7.22 | 7.30 | 7.10 | 28.99 | 1.55 | -0.02 (-0.28%) | 98.90% | 143.92% | 25.85M | 4.90 | 47.22% | 3.58 | 101.61% |
D Sell |
| 135 | TTPH | Tetraphase Pharmaceuticals, Inc. | 2.53 | 2.60 | 2.60 | 2.52 | 10.40 | 0.56 | -0.05 (-1.94%) | -9.96% | -74.19% | 18.38M | 2.20 | 14.84% | 2.48 | 2.00% |
D Sell |
| 136 | SXTC | China SXT Pharmaceuticals, Inc. | 0.55 | 0.55 | 0.57 | 0.53 | 3.22 | 0.34 | -0.02 (-3.88%) | -32.93% | -82.30% | 15.16M | 0.47 | 16.17% | 0.77 | -28.70% |
D Sell |
| 137 | CGC | Canopy Growth Corporation | 16.33 | 16.61 | 16.68 | 16.15 | 39.67 | 9.00 | -0.17 (-1.03%) | -22.57% | -58.64% | 5.73B | 16.72 | -2.34% | 18.41 | -11.32% |
F Strong Sell |
| 138 | AMRN | Amarin Corporation plc, each representing one Ordinary Share | 6.77 | 6.70 | 6.80 | 6.61 | 26.12 | 3.95 | 0.03 (0.45%) | -68.42% | -70.77% | 2.61B | 7.15 | -5.30% | 14.03 | -51.74% |
F Strong Sell |
| 139 | ZGNX | Zogenix, Inc. | 28.28 | 27.65 | 28.40 | 27.28 | 57.22 | 16.65 | 0.70 (2.54%) | -45.75% | -40.69% | 1.57B | 28.46 | -0.63% | 36.59 | -22.71% |
F Strong Sell |
| 140 | ACB | Aurora Cannabis Inc. Common Shares | 12.16 | 12.42 | 12.49 | 12.00 | 89.76 | 5.30 | -0.26 (-2.09%) | -53.09% | -86.38% | 1.38B | 12.27 | -0.90% | 23.06 | -47.27% |
F Strong Sell |
| 141 | ARVN | Arvinas, Inc. | 33.93 | 33.64 | 34.32 | 33.26 | 61.57 | 15.19 | 0.54 (1.62%) | -17.43% | 31.05% | 1.33B | 40.00 | -15.18% | 38.79 | -12.52% |
F Strong Sell |
| 142 | CNST | Constellation Pharmaceuticals, Inc. | 30.73 | 30.15 | 30.83 | 29.59 | 59.49 | 6.01 | 0.53 (1.75%) | -34.77% | 215.83% | 1.29B | 36.22 | -15.16% | 32.30 | -4.86% |
F Strong Sell |
| 143 | AIMT | Aimmune Therapeutics, Inc. | 16.57 | 16.78 | 17.03 | 16.26 | 37.00 | 10.09 | -0.21 (-1.25%) | -50.49% | -20.72% | 1.08B | 17.41 | -4.83% | 23.29 | -28.84% |
F Strong Sell |
| 144 | NBRV | Nabriva Therapeutics plc - Ordinary Shares | 0.69 | 0.73 | 0.73 | 0.68 | 2.77 | 0.49 | -0.01 (-1.32%) | -47.73% | -71.84% | 986.41M | 0.72 | -3.97% | 1.26 | -45.08% |
F Strong Sell |
| 145 | TLRY | Tilray, Inc. - Class 2 | 7.58 | 7.73 | 7.94 | 7.45 | 46.67 | 2.43 | -0.12 (-1.56%) | -55.75% | -83.32% | 946.45M | 8.49 | -10.75% | 14.47 | -47.61% |
F Strong Sell |
| 146 | ENDP | Endo International plc - Ordinary Shares | 3.41 | 3.62 | 3.63 | 3.33 | 7.10 | 1.97 | -0.21 (-5.80%) | -27.29% | -19.39% | 783.29M | 3.87 | -11.85% | 4.39 | -22.26% |
F Strong Sell |
| 147 | AERI | Aerie Pharmaceuticals, Inc. | 13.41 | 13.36 | 13.49 | 12.86 | 26.34 | 10.80 | 0.09 (0.68%) | -44.52% | -47.41% | 623.14M | 14.95 | -10.30% | 18.16 | -26.14% |
F Strong Sell |
| 148 | MGTX | MeiraGTx Holdings plc - Ordinary Shares | 12.47 | 11.84 | 12.47 | 11.79 | 30.23 | 8.82 | 0.60 (5.05%) | -37.71% | -56.88% | 465.90M | 13.98 | -10.77% | 15.91 | -21.62% |
F Strong Sell |
| 149 | MGTA | Magenta Therapeutics, Inc. | 8.94 | 9.11 | 9.16 | 8.70 | 16.19 | 5.76 | 0.11 (1.25%) | -41.03% | -33.03% | 352.99M | 9.18 | -2.64% | 10.62 | -15.83% |
F Strong Sell |
| 150 | MNLO | Menlo Therapeutics Inc. | 1.70 | 1.75 | 1.76 | 1.66 | 7.48 | 1.00 | -0.03 (-1.73%) | -63.36% | -67.50% | 284.96M | 1.99 | -14.47% | 3.60 | -52.82% |
F Strong Sell |
| 151 | OGI | Organigram Holdings Inc. | 1.54 | 1.63 | 1.64 | 1.53 | 7.31 | 1.09 | -0.05 (-3.14%) | -37.14% | -78.25% | 270.58M | 1.68 | -8.51% | 2.33 | -33.95% |
F Strong Sell |
| 152 | LCI | Lannett Co Inc | 6.39 | 6.70 | 6.70 | 6.11 | 15.52 | 5.46 | -0.25 (-3.77%) | -27.55% | 7.94% | 257.84M | 7.65 | -16.48% | 8.84 | -27.73% |
F Strong Sell |
| 153 | MNK | Mallinckrodt plc Ordinary Shares | 2.42 | 2.40 | 2.44 | 2.35 | 8.77 | 1.00 | -0.02 (-0.82%) | -30.66% | -70.91% | 204.38M | 2.94 | -17.57% | 3.25 | -25.59% |
F Strong Sell |
| 154 | RFL | Rafael Holdings, Inc. Class B | 12.74 | 12.91 | 13.45 | 12.71 | 23.76 | 9.40 | -0.38 (-2.90%) | -28.59% | -43.83% | 201.51M | 14.38 | -11.43% | 16.76 | -23.98% |
F Strong Sell |
| 155 | CHMA | Chiasma, Inc. | 4.51 | 4.70 | 4.73 | 4.50 | 9.25 | 2.88 | -0.15 (-3.22%) | -9.07% | -36.83% | 190.62M | 5.92 | -23.76% | 5.05 | -10.62% |
F Strong Sell |
| 156 | VTVT | vTv Therapeutics Inc. - | 2.30 | 2.18 | 2.31 | 2.11 | 4.23 | 1.23 | 0.10 (4.32%) | 35.29% | 60.49% | 155.88M | 2.58 | -10.77% | 2.11 | 9.05% |
F Strong Sell |
| 157 | BFRA | Biofrontera AG | 6.00 | 6.20 | 6.20 | 6.00 | 17.25 | 5.41 | -0.19 (-3.07%) | -42.31% | -65.22% | 134.55M | 7.38 | -18.74% | 11.96 | -49.81% |
F Strong Sell |
| 158 | RMTI | Rockwell Medical, Inc. | 1.84 | 1.88 | 1.89 | 1.78 | 3.85 | 1.31 | -0.04 (-2.13%) | -24.59% | -39.27% | 127.09M | 2.09 | -11.91% | 2.35 | -21.70% |
F Strong Sell |
| 159 | ELOX | Eloxx Pharmaceuticals, Inc. | 2.85 | 2.86 | 3.01 | 2.73 | 9.70 | 1.44 | -0.01 (-0.35%) | -61.28% | -69.35% | 114.36M | 3.11 | -8.27% | 3.98 | -28.48% |
F Strong Sell |
| 160 | SVRA | Savara, Inc. | 2.18 | 2.18 | 2.23 | 2.14 | 5.48 | 0.69 | 0.00 (0.00%) | -51.34% | -18.05% | 113.77M | 2.49 | -12.37% | 2.14 | 1.79% |
F Strong Sell |
| 161 | EOLS | Evolus, Inc. | 3.35 | 3.73 | 3.77 | 3.32 | 20.27 | 3.08 | -0.51 (-13.21%) | -72.47% | -77.67% | 112.99M | 4.78 | -29.87% | 9.21 | -63.61% |
F Strong Sell |
| 162 | CKPT | Checkpoint Therapeutics, Inc. | 1.92 | 1.94 | 1.98 | 1.83 | 3.42 | 1.05 | 0.15 (8.47%) | 11.63% | -38.26% | 105.71M | 1.97 | -2.37% | 1.78 | 7.95% |
F Strong Sell |
| 163 | APM | Aptorum Group Limited - Class A Ordinary Shares | 3.45 | 3.36 | 3.66 | 3.31 | 23.75 | 1.66 | 0.05 (1.47%) | -78.23% | -85.04% | 99.96M | 3.49 | -1.26% | 9.80 | -64.79% |
F Strong Sell |
| 164 | XERS | Xeris Pharmaceuticals, Inc. | 2.64 | 2.63 | 2.76 | 2.57 | 12.94 | 1.42 | 0.03 (1.15%) | -62.55% | -78.04% | 99.23M | 4.01 | -34.21% | 5.43 | -51.40% |
F Strong Sell |
| 165 | MIST | Milestone Pharmaceuticals Inc. | 3.89 | 3.72 | 3.89 | 3.66 | 24.01 | 1.69 | 0.09 (2.37%) | -75.70% | -80.44% | 95.79M | 3.64 | 6.80% | 12.72 | -69.41% |
F Strong Sell |
| 166 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.72 | 0.72 | 0.74 | 0.72 | 2.69 | 0.70 | -0.01 (-1.97%) | -53.55% | -55.82% | 89.83M | 0.85 | -14.89% | 1.38 | -47.68% |
F Strong Sell |
| 167 | ACRX | AcelRx Pharmaceuticals, Inc. | 1.10 | 1.18 | 1.18 | 1.05 | 3.02 | 0.70 | -0.03 (-2.65%) | -47.87% | -55.10% | 88.84M | 1.39 | -21.11% | 1.66 | -33.82% |
F Strong Sell |
| 168 | ZYNE | Zynerba Pharmaceuticals, Inc. | 3.42 | 3.25 | 3.44 | 3.20 | 15.30 | 2.55 | 0.17 (5.23%) | -43.38% | -77.09% | 85.33M | 4.92 | -30.48% | 5.44 | -37.10% |
F Strong Sell |
| 169 | CLSD | Clearside Biomedical, Inc. | 1.87 | 1.88 | 1.89 | 1.83 | 4.13 | 0.56 | -0.02 (-1.06%) | -35.52% | 71.56% | 83.91M | 1.97 | -5.18% | 1.90 | -1.53% |
F Strong Sell |
| 170 | PTI | Proteostasis Therapeutics, Inc. | 1.39 | 1.37 | 1.39 | 1.34 | 4.72 | 0.61 | 0.03 (2.21%) | -39.04% | 36.27% | 72.49M | 1.52 | -8.27% | 1.55 | -10.09% |
F Strong Sell |
| 171 | ADMS | Adamas Pharmaceuticals, Inc. | 2.57 | 2.58 | 2.62 | 2.53 | 7.78 | 1.90 | 0.01 (0.39%) | -32.19% | -55.84% | 72.37M | 2.84 | -9.60% | 4.12 | -37.57% |
F Strong Sell |
| 172 | SCYX | SCYNEXIS, Inc. | 0.72 | 0.72 | 0.73 | 0.71 | 1.44 | 0.50 | -0.01 (-0.89%) | -20.88% | -44.20% | 71.12M | 0.82 | -12.35% | 0.93 | -22.28% |
F Strong Sell |
| 173 | SYBX | Synlogic, Inc. | 2.11 | 2.07 | 2.14 | 2.00 | 9.13 | 1.35 | 0.05 (2.43%) | -18.22% | -76.50% | 69.29M | 2.20 | -4.25% | 2.24 | -5.84% |
F Strong Sell |
| 174 | ASRT | Assertio Therapeutics, Inc. | 0.80 | 0.81 | 0.81 | 0.79 | 3.55 | 0.55 | -0.02 (-1.97%) | -36.00% | -75.31% | 65.10M | 0.88 | -9.03% | 0.97 | -17.72% |
F Strong Sell |
| 175 | ARDS | Aridis Pharmaceuticals Inc. | 6.40 | 6.30 | 6.40 | 6.26 | 12.40 | 3.80 | 0.05 (0.79%) | 43.82% | -37.74% | 57.11M | 7.16 | -10.58% | 6.23 | 2.74% |
F Strong Sell |
| 176 | CPIX | Cumberland Pharmaceuticals Inc. | 3.28 | 3.24 | 3.31 | 3.24 | 6.27 | 3.10 | -0.03 (-0.91%) | -36.31% | -46.99% | 49.79M | 3.52 | -6.86% | 4.48 | -26.72% |
F Strong Sell |
| 177 | OPNT | Opiant Pharmaceuticals, Inc. | 9.42 | 9.11 | 9.45 | 9.10 | 18.23 | 8.05 | 0.27 (2.95%) | -34.58% | -27.54% | 40.11M | 10.35 | -8.96% | 12.34 | -23.69% |
F Strong Sell |
| 178 | ETTX | Entasis Therapeutics Holdings Inc. | 2.54 | 2.60 | 2.65 | 2.48 | 9.25 | 1.75 | -0.08 (-3.05%) | -48.89% | -60.01% | 37.12M | 2.76 | -8.01% | 4.24 | -40.15% |
F Strong Sell |
| 179 | ALNA | Allena Pharmaceuticals, Inc. | 1.47 | 1.48 | 1.48 | 1.39 | 6.30 | 0.53 | 0.01 (0.68%) | -46.15% | -69.82% | 36.37M | 1.80 | -18.41% | 2.36 | -37.74% |
F Strong Sell |
| 180 | HOTH | Hoth Therapeutics, Inc. | 2.65 | 2.72 | 2.74 | 2.45 | 7.87 | 2.31 | 0.11 (4.33%) | -57.19% | -53.75% | 35.56M | 3.04 | -12.83% | 4.00 | -33.73% |
F Strong Sell |
| 181 | NEOS | Neos Therapeutics, Inc. | 0.70 | 0.69 | 0.72 | 0.68 | 2.15 | 0.60 | 0.01 (1.46%) | -53.64% | -49.27% | 34.83M | 0.76 | -8.19% | 1.22 | -42.66% |
F Strong Sell |
| 182 | ECOR | electroCore, Inc. | 0.83 | 0.88 | 0.90 | 0.83 | 5.64 | 0.32 | -0.03 (-2.92%) | -47.80% | -52.93% | 31.77M | 0.94 | -11.99% | 1.26 | -33.87% |
F Strong Sell |
| 183 | SBPH | Spring Bank Pharmaceuticals, Inc. | 1.56 | 1.53 | 1.56 | 1.52 | 5.70 | 0.80 | 0.06 (4.00%) | -1.27% | -68.23% | 26.67M | 1.55 | 0.54% | 2.01 | -22.37% |
F Strong Sell |
| 184 | ITRM | Iterum Therapeutics plc - Ordinary Share | 1.20 | 1.19 | 1.22 | 1.17 | 7.65 | 1.12 | -0.02 (-1.64%) | -73.33% | -81.60% | 21.42M | 2.49 | -51.85% | 2.96 | -59.41% |
F Strong Sell |
| 185 | ADIL | Adial Pharmaceuticals, Inc | 1.50 | 1.55 | 1.55 | 1.46 | 3.17 | 1.00 | -0.01 (-0.66%) | -37.76% | -16.67% | 20.18M | 1.48 | 1.41% | 1.60 | -6.46% |
F Strong Sell |
| 186 | NTEC | Intec Pharma Ltd. - Ordinary Shares | 0.29 | 0.29 | 0.29 | 0.28 | 4.37 | 0.13 | 0.00 (0.00%) | -42.00% | -92.20% | 19.95M | 0.30 | -3.16% | 0.42 | -30.96% |
F Strong Sell |
| 187 | ZOM | Zomedica Pharmaceuticals Corp. Common Shares | 0.18 | 0.18 | 0.18 | 0.17 | 0.50 | 0.11 | 0.00 (2.86%) | -45.62% | -29.51% | 19.07M | 0.20 | -11.56% | 0.25 | -29.33% |
F Strong Sell |
| 188 | VVUS | VIVUS, Inc. | 0.68 | 0.52 | 0.69 | 0.51 | 4.75 | 0.51 | -0.13 (-15.79%) | -75.00% | -82.11% | 12.15M | 1.08 | -37.01% | 2.18 | -68.85% |
F Strong Sell |
| 189 | TENX | Tenax Therapeutics, Inc. | 0.92 | 0.94 | 0.94 | 0.90 | 2.68 | 0.25 | -0.03 (-3.07%) | -34.75% | -33.33% | 8.48M | 1.04 | -11.27% | 1.08 | -14.73% |
F Strong Sell |
| 190 | SNES | SenesTech, Inc. | 1.94 | 1.99 | 2.02 | 1.94 | 36.60 | 1.32 | -0.09 (-4.43%) | -82.36% | -94.49% | 6.58M | 2.00 | -2.95% | 7.48 | -74.06% |
F Strong Sell |
| NR | AGN | Allergan plc Ordinary Shares | 193.02 | 193.01 | 193.38 | 191.64 | 202.21 | 114.27 | 0.03 (0.02%) | 1.74% | 37.82% | 63.50B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | BITI | Biotie Therapies Cor | 25.80 | 26.52 | 26.52 | 25.69 | 27.96 | 12.43 | -0.71 (-2.68%) | 79.79% | 25.18% | 351.40M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ERYP | Erytech Pharma S.A. | 8.58 | 8.58 | 8.58 | 8.58 | 12.00 | 3.50 | 0.58 (7.25%) | 16.34% | 22.57% | 153.93M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | OASM | Oasmia Pharmaceutical AB | 1.55 | 1.57 | 1.57 | 1.55 | 5.70 | 0.94 | 0.03 (1.97%) | -48.68% | -13.89% | 116.20M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | NTGN | Neon Therapeutics, Inc. | 3.07 | 2.96 | 3.09 | 2.91 | 6.25 | 0.88 | 0.23 (8.10%) | 160.17% | -49.92% | 88.93M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | AQXP | Aquinox Pharmaceuticals, Inc. | 3.68 | 3.50 | 3.84 | 3.46 | 3.84 | 2.00 | 0.21 (6.05%) | 70.37% | 16.09% | 86.62M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | HAPP | HAPPINESS BIOTECH GROUP LTD | 2.73 | 2.76 | 2.79 | 2.70 | 6.10 | 2.44 | -0.04 (-1.44%) | -40.07% | -39.33% | 68.25M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ASNS | Arsanis, Inc. | 3.11 | 3.24 | 3.78 | 3.05 | 28.69 | 1.15 | -0.13 (-3.86%) | 34.05% | -86.33% | 45.54M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CNSP | CNS PHARMACEUTICALS, INC. | 2.06 | 2.15 | 2.17 | 1.97 | 5.69 | 1.26 | 0.11 (5.64%) | -47.85% | -54.92% | 33.89M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CORV | Correvio Pharma Corp. - Ordinary Shares (Canada) | 0.42 | 0.42 | 0.42 | 0.42 | 2.79 | 0.21 | 0.00 (0.82%) | 2.44% | -81.74% | 27.79M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | AKRX | Akorn, Inc. | 0.09 | 0.18 | 0.20 | 0.09 | 5.46 | 0.09 | -0.09 (-51.01%) | -94.00% | -97.80% | 11.98M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CXRX | Concordia International Corp. | 0.19 | 0.19 | 0.20 | 0.19 | 1.80 | 0.19 | 0.00 (0.00%) | -71.21% | -84.55% | 9.74M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | SGYP | Synergy Pharmaceuticals, Inc. | 0.03 | 0.06 | 0.06 | 0.03 | 2.23 | 0.03 | -0.03 (-52.00%) | -73.68% | -98.65% | 7.44M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | IPCI | Intellipharmaceutics International Inc. | 0.21 | 0.22 | 0.27 | 0.21 | 6.60 | 0.20 | -0.06 (-22.00%) | -13.22% | -96.60% | 4.60M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | GEMP | Gemphire Therapeutics Inc. | 0.30 | 0.31 | 0.34 | 0.29 | 1.49 | 0.24 | 0.00 (-0.37%) | -98.52% | -61.04% | 4.46M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | SNNA | Sienna Biopharmaceuticals, Inc. | 0.14 | 0.10 | 0.17 | 0.10 | 3.80 | 0.06 | 0.03 (34.46%) | -93.97% | -96.10% | 4.33M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PTX | Pernix Therapeutics Holdings, Inc. | 0.21 | 0.22 | 0.24 | 0.20 | 3.30 | 0.20 | -0.01 (-4.55%) | -50.00% | -92.76% | 3.05M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ARDM | Aradigm Corporation | 0.12 | 0.31 | 0.35 | 0.07 | 2.33 | 0.07 | -0.34 (-73.91%) | -62.50% | -90.77% | 1.83M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | TRPX | Therapix Biosciences Ltd. | 0.32 | 0.36 | 0.40 | 0.30 | 4.69 | 0.25 | -0.30 (-48.90%) | -71.33% | -87.22% | 1.11M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ARGS | Argos Therapeutics, Inc. | 0.10 | 0.10 | 0.11 | 0.10 | 4.00 | 0.07 | 0.00 (0.00%) | -33.33% | -97.06% | 1.06M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ORTX | Orchard Therapeutics plc | 5.20 | 5.26 | 5.32 | 5.11 | 17.48 | 5.11 | -0.02 (-0.38%) | -62.18% | -61.65% | 505.77M | 8.62 | -39.66% | 10.87 | -52.18% |
NR Not Rated |
| NR | HOOK | HOOKIPA Pharma Inc. | 10.30 | 10.53 | 10.92 | 9.92 | 14.37 | 5.80 | -0.41 (-3.83%) | -15.78% | 57.01% | 224.80M | 10.53 | -2.22% | 9.68 | 6.36% |
NR Not Rated |
| NR | SNDL | Sundial Growers Inc. | 0.78 | 0.79 | 0.79 | 0.75 | 13.22 | 0.37 | 0.01 (1.30%) | -74.09% | -90.80% | 83.74M | 0.76 | 3.24% | 1.97 | -60.41% |
NR Not Rated |
All price changes on this page include dividends and splits.